Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.

EAE disease prevention by a potent oral RORγt inverse agonist INV-17: A promising safe & efficacious ms treatment

Journal of the Neurological Sciences(2013)10.1016/j.jns.2013.07.1327Source: DataRank Database

EAE disease prevention by a potent oral RORγt inverse agonist INV-17: A promising safe & efficacious ms treatment is a research paper published in Journal of the Neurological Sciences (2013). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

0 citations · base score 0

Cite:

datarank_citation_only_1hop_v6· scope data_onlyMethodology

›Data sources & pipeline

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Pending

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

Authors (5)

S. Palmer,R. Shamilov,M. FisherORCID,J. Tilley,A. Gaweco

EAE disease prevention by a potent oral RORγt inverse agonist INV-17: A promising safe &amp; efficacious ms treatment

FAIR Checklist

Authors (5)

EAE disease prevention by a potent oral RORγt inverse agonist INV-17: A promising safe & efficacious ms treatment